EMED's New Accusert Needle Inserter Obtains FDA Clearance
March 8, 2023
El Dorado Hills, CA - EMED is pleased to announce that its Accusert® needle insertion device has obtained FDA clearance. Accusert® is to be used in conjunction with OPTflow® subcutaneous needle sets. OPTflow® and Accusert® optimize patient care and clinical protocols to improve the patient experience.
EMED subcutaneous sets have been cleared for general use by FDA, CE, CANADA, LATAM, and Asian markets. The sets include universal luer locks that allow for them to be connected to most infusion devices globally. The EMED sub-q sets are increasingly the preferred option in multiple countries around the world.
El Dorado Hills, California, March 7, 2023: EMED is pleased to announce that its Accusert needle insertion device has obtained FDA clearance in Q4 2022 510(k) Premarket Notification (fda.gov). Accusert® is to be used in conjunction with OPTflow®subcutaneous needle sets.
OPTflow® and Accusert® optimize patient care and clinical protocols to improve the patient experience. Both devices are proprietary and have multiple issued and pending patents. EMED is ramping up inventory to meet the increasing demand for OPTflow® sets and Accusert® with global distribution.
EMED subcutaneous sets have been cleared for general use by FDA, CE, CANADA, LATAM, and Asian markets. The sets include universal luer locks that allow for the to be connected to most infusion devices globally.
EMED has been a global innovator in the infusion technology market for decades. It has produced best-in-class needles since the 1990’s and pioneered SCIG needle designs and infusion technology.
“Our Accusert® reusable device is an environmentally friendly clinical asset to patients. Distributors are increasing our footprint globally” said Paul Lambert, CEO of EMED Technologies Corporation.
EMED continues to be focused on breakthrough innovations for SCIG to optimize the patient experience.
EMED has invested millions of dollars in conducting R&D of novel devices for SCIG and will continue to take the lead globally. Our pipeline of infusion device platforms offers unique benefits to patients, clinicians and Ig manufacturers.
About EMED
EMED Technologies is an industry leader in the design, manufacture, and distribution of cutting-edge medical devices. For two decades, EMED Technologies has worked with clinicians, inventors, and medical companies to develop innovative medical products. Today, we are proud that both patients and clinicians can benefit from the fruits of our labor because we offer a wide variety of products and services that improve therapies and enhance clinical benefits. Also, with our dynamic team of professionals, EMED continues to work with clinicians to understand their requirements and improve upon available technologies, and we are confident that these endeavors will benefit generations to come! In addition to novel technology, EMED is proud to offer licensing agreements for patented and proprietary technologies.
Media contact